Department of Biological Sciences, North Carolina State University, Raleigh, NC, 27695-7633, USA.
Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Box 800734, Jordan Hall 7315, Charlottesville, VA, 22908, USA.
Sci Rep. 2017 Jun 7;7(1):2918. doi: 10.1038/s41598-017-03112-1.
Programmed cell death (PCD) occurs in several forms including apoptosis and necroptosis. Apoptosis is executed by the activation of caspases, while necroptosis is dependent on the receptor interacting protein kinase 3 (RIPK3). Precise control of cell death is crucial for tissue homeostasis. Indeed, necroptosis is triggered by caspase inhibition to ensure cell death. Here we identified a previously uncharacterized cell death pathway regulated by TAK1, which is unexpectedly provoked by inhibition of caspase activity and necroptosis cascades. Ablation of TAK1 triggers spontaneous death in macrophages. Simultaneous inhibition of caspases and RIPK3 did not completely restore cell viability. Previous studies demonstrated that loss of TAK1 in fibroblasts causes TNF-induced apoptosis and that additional inhibition of caspase leads to necroptotic cell death. However, we surprisingly found that caspase and RIPK3 inhibitions do not completely suppress cell death in Tak1-deficient cells. Mechanistically, the execution of the third cell death pathway in Tak1-deficient macrophages and fibroblasts were mediated by RIPK1-dependent rapid accumulation of reactive oxygen species (ROS). Conversely, activation of RIPK1 was sufficient to induce cell death. Therefore, loss of TAK1 elicits noncanonical cell death which is mediated by RIPK1-induced oxidative stress upon caspase and necroptosis inhibition to further ensure induction of cell death.
程序性细胞死亡 (PCD) 有多种形式,包括细胞凋亡和坏死性凋亡。细胞凋亡是通过半胱天冬酶的激活来执行的,而坏死性凋亡则依赖于受体相互作用蛋白激酶 3 (RIPK3)。细胞死亡的精确控制对于组织稳态至关重要。事实上,通过抑制半胱天冬酶来触发坏死性凋亡,以确保细胞死亡。在这里,我们鉴定了一种以前未被表征的由 TAK1 调节的细胞死亡途径,该途径出乎意料地被半胱天冬酶活性和坏死性凋亡级联的抑制所引发。TAK1 的缺失会触发巨噬细胞的自发性死亡。同时抑制半胱天冬酶和 RIPK3 并不能完全恢复细胞活力。先前的研究表明,成纤维细胞中 TAK1 的缺失会导致 TNF 诱导的细胞凋亡,并且额外抑制半胱天冬酶会导致坏死性细胞死亡。然而,我们惊讶地发现,caspase 和 RIPK3 的抑制并不能完全抑制 Tak1 缺陷细胞的细胞死亡。从机制上讲,Tak1 缺陷的巨噬细胞和成纤维细胞中第三种细胞死亡途径的执行是由 RIPK1 依赖性活性氧 (ROS) 的快速积累介导的。相反,RIPK1 的激活足以诱导细胞死亡。因此,TAK1 的缺失会引发非典型细胞死亡,这是由 caspase 和坏死性凋亡抑制后 RIPK1 诱导的氧化应激介导的,以进一步确保细胞死亡的诱导。